Skip to main content

Table 1 ATLAS surveillance reporting Performance Measures

From: Establishment of a sentinel surveillance network for sexually transmissible infections and blood borne viruses in Aboriginal primary care services across Australia: the ATLAS project

Performance measures Definition
1. STI Testing Rate Proportion of clients tested for STIs (CT, NG, TV, syphilis and HIV) during the reporting period
2. STI Testing Coverage Proportion of current clients tested for STIs at least once in a 12-month period
3. STI test positivity Proportion of clients with at least one positive STI test in a 12-month period
4. Completeness of STI Testing Proportion of clients with a positive CT and/or NG and/or TV result also tested for syphilis and HIV within 30 days of date of initial specimen collection
5. STI Treatment Interval Time (days) from date of positive STI (CT, NG, TV) test to date of treatment
6. STI Retesting Rate Proportion of clients retested at approximately three months (60 to 120 days) following treatment for an initial positive STI (CT/NG/TV) result
7. STI Repeat Positivity Rate Proportion of clients retested at approximately three months (60 to 120 days) after treatment for an initial positive CT/NG result and who retested positive for CT/NG at this time
8. Hepatitis B Virus (HBV) Testing Rate Proportion of clients receiving an HBV test. Among those testing negative, the proportion who subsequently received one or more dose of vaccination.
9. Hepatitis C (HCV) Testing Rate Proportion of clients receiving an HCV antibody test and among those testing positive, the proportion then tested for RNA or viral load.
10. HCV Treatment Uptake Proportion of HCV RNA positive clients prescribed Direct Acting Antiviral (DAA) treatment
11. HCV Sustained Virological Response Proportion of clients who, after having been prescribed DAA treatment, achieve an undetectable viral load
12. HPV Screening Rate Proportion of female clients screened for human papillomavirus in line with national guidelines
  1. Clients: all patients aged 15 years or older attending the health service for a clinical encounter or consultation with a medical doctor, nurse or Aboriginal health practitioner
  2. Abbreviations: CT Chlamydia trachomatis, DAA Direct Acting Antiviral, HBV Hepatitis B Virus, HCV Hepatitis C Virus, HIV Human Immunodeficiency Virus, HPV Human Papillomavirus, NG Neisseria gonorrhoeae, STI Sexually Transmissible Infection, TV Trichomonas vaginalis
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us